Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial

BACKGROUND: Little is known about the specific reasons for antipsychotic discontinuation or continuation from patients’ or clinicians’ perspectives. This study aimed to assess the construct validity of 2 new measures of the Reasons for Antipsychotic Discontinuation/Continuation (RAD): RAD-I (a struc...

Descripción completa

Detalles Bibliográficos
Autores principales: Faries, Douglas, Ascher-Svanum, Haya, Phillips, Glenn, Nyhuis, Allen W, Sugihara, Tomoko, Stauffer, Virginia, Kinon, Bruce J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505169/
https://www.ncbi.nlm.nih.gov/pubmed/22974273
http://dx.doi.org/10.1186/1471-2288-12-142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505169/
https://www.ncbi.nlm.nih.gov/pubmed/22974273
http://dx.doi.org/10.1186/1471-2288-12-142

Ejemplares similares